Evidence map›Paper›PMID 37745978›Full record

ArticleOpen medicine (Warsaw, Poland)2023

A prognostic signature based on seven T-cell-related cell clustering genes in bladder urothelial carcinoma.

Jie Yang, Fenghai Zhou, Xia Yang, Pengcheng Ma, Xiaoling Ma

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open medicine (Warsaw, Poland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jie YangThe First School of Clinical Medicine, Lanzhou University/Department of Reproductive Medicine, The First Hospital of Lanzhou University, Lanzhou, Gansu, 730000, P.R. China.
Fenghai ZhouThe First School of Clinical Medicine, Lanzhou University/Department of Urology, Gansu Provincial Hospital, No. 204 Donggang West Road, Chengguan District, Lanzhou, Gansu, 730000, P.R. China.
Xia YangDepartment of Reproductive Medicine, The First Hospital of Lanzhou University, Lanzhou, Gansu, 730000, P.R. China.
Pengcheng MaDepartment of Reproductive Medicine, The First Hospital of Lanzhou University, Lanzhou, Gansu, 730000, P.R. China.
Xiaoling MaDepartment of Reproductive Medicine, The First Hospital of Lanzhou University, Lanzhou, Gansu, 730000, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bladder urothelial carcinoma (BLCA) is one of the most common cancer-related deaths in the world, along with high mortality. Due to the difficult detection of early symptoms, the treatment for this disease is still dissatisfactory. Thus, the current research hotspot is beginning to focus on the immune microenvironment in this disease, aiming to provide guidance for diagnosis and treatment. In this study, the single-cell RNA sequencing data downloaded from the gene expression omnibus database was used to classify the immune cells of BLCA. And the final seven T-cell-related cell clustering genes associated with BLCA prognosis (

Indexed as

bladder urothelial carcinomaimmune microenvironmentprognosissingle-cell RNA sequencing

Identifiers

PMID37745978
PMCPMC10512444

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.